1. Concord Biotech
stock logo

34% Hold

Concord Biotech Share Price

CONCORDBIO

₹1,501.30-₹51.90 (-3.34%) TodayLast updated on 09 May, 2024 | 03:46 PM IST
₹1,491.40₹1,567.35
L
Show Current Price
H
  • News

  • Company overview

  • Fundamentals

  • Events

  • More

Company overview

About

arrow

Market cap

Market Cap Switch₹16,249 Cr

Open

₹1,550.00

Close

₹1,553.20

Circuit range

₹1,863.80 - ₹1,242.60

Day range

₹1,491.40 - ₹1,567.35

Year range

₹900.05 - ₹1,725.00

Volume

30,416

Avg. traded

₹1,518.79

Revenue (12m)

₹971 Cr

Concord BiotechConcord Biotech Limited is an India-based research and development driven biopharma company. The Company is engaged in the research and development, manufacturing, marketing, and selling of pharmaceutical products. The Company manufactures active pharmaceutical ingredients (API) through fermentation and semi-synthetic processes and finished formulations. It manufactures fermentation and semi-synthetic based products in the therapeutic segments, such as immunosuppressants, anti-bacterial, oncology, anti-fungal and others. Its API products include Mycophenolate Mofetil, Mycophenolate Sodium, Cyclosporine, Vancomycin Hydrochloride, Micafungin Sodium, Mupirocin, Romidepsin, Dactinomycin, and Pravastatin Sodium, among others. It also has a pipeline of API products under development. Its API products under development include Polymyxin B, Fidaxomicin, Doxorubicin, and others. The Company provides products in the critical care, immunology, nephrology, and transplant medicine segments.

Read more

Concord Biotech Key indicators

arrow

52 week high

₹1,725.00

52 week low

₹900.05

P/E ratio

54.01

P/B ratio

11.36

ROE

19.85%

ROCE

26.48%

Dividend yield

0.44%

Debt/Equity ratio

0.02

EPS

22.76

Learn more

Investment checklist: (2/6)

arrow
check status

Equity returns

check status

Dividend returns

check status

Safety factor

check status

Growth factor

check status

Debt vs Equity

check status

Profit factor

The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily

Analyst ratings:

Hold

arrow

Buy

33%

Hold

34%

Sell

33%

This analysis is based on the reviews of 3 experts in the last 7 days

Fundamentals

Financial ratios

arrow
  • Profitability

  • Operational

  • Valuation

Operating profit margin

45%

Net profit margin

27.91%

ROE

19.85%

ROA

14.87%

ROCE

26.48%

Learn more

Concord Biotech Shareholder returns

arrow

1 day

-0.25%

1 week

-6.83%

1 month

+1.81%

3 months

+5.28%

1 year

+64.74%

3 years

+64.74%

5 years

+64.74%

Revenue statement

All values are in ₹ Crores (Cr)
arrow
Empty state

No data available at the moment

Cash flow

All values are in ₹ Crores (Cr)
arrow
Empty state

No data available at the moment

Balance sheet

All values are in ₹ Crores (Cr)
arrow
Empty state

No data available at the moment

Concord Biotech Share Price history

arrow
DayOpenCloseDay’s change
Wed, May 8 2024
₹1,557.00
₹1,553.20
-0.24%
Tue, May 7 2024
₹1,563.00
₹1,557.05
-0.38%
Mon, May 6 2024
₹1,641.00
₹1,578.55
-3.96%
Fri, May 3 2024
₹1,655.00
₹1,617.75
-2.30%
Thu, May 2 2024
₹1,661.35
₹1,658.90
-0.15%
Tue, Apr 30 2024
₹1,655.00
₹1,667.10
+0.73%
Mon, Apr 29 2024
₹1,684.50
₹1,650.45
-2.06%
Fri, Apr 26 2024
₹1,649.90
₹1,660.05
+0.61%

Shareholding info

arrow

Promoters (44.08%)

Mutual Funds (5.15%)

Retail and other (41.03%)

Foreign institutions-FII (6.49%)

Other domestic institutions (3.25%)

Promoters

Learn more

Events

Empty state

No data available at the moment

More

Similar stocks

arrow
Empty state

No data available at the moment

People also bought

arrow
Empty state

No data available at the moment

Frequently asked questions